The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Travere Therapeutics Inc shares valued at $122,356 were sold by ROTE WILLIAM E. on Feb 12 ’25. At $23.53 per share, ROTE WILLIAM E. sold 5,200 shares. The insider’s holdings dropped to 98,519 shares worth approximately $1.91 million following the completion of this transaction.
Also, REED ELIZABETH E sold 8,000 shares, netting a total of over 188,240 in proceeds. Following the sale of shares at $23.53 each, the insider now holds 89,482 shares.
Before that, Calvin Sandra had sold 54,244 shares from its account. In a trade valued at $1,356,100, the SVP, CHIEF ACCOUNTING OFFICER traded Travere Therapeutics Inc shares for $25.00 each. Upon closing the transaction, the insider’s holdings decreased to 54,244 shares, worth approximately $1.06 million.
As published in their initiating research note from Cantor Fitzgerald on January 10, 2025, Travere Therapeutics Inc [TVTX] has been an Overweight. Analysts at Wells Fargo upgraded the stock from ‘”an Equal weight”‘ to ‘”an Overweight”‘ outlook in a report released in late October. As of October 16, 2024, Scotiabank has initiated its “Sector outperform” rating for TVTX. Earlier on September 09, 2024, Guggenheim upgraded its rating. Their new recommendation was “a Buy” for TVTX stock which previously was a “a Neutral”.
Analyzing TVTX Stock Performance
During the last five days, there has been a drop of approximately -7.70%. Over the course of the year, Travere Therapeutics Inc shares have jumped approximately 11.42%. Shares of the company reached a 52-week high of $25.29 on 02/11/25 and a 52-week low of $16.80 on 01/14/25. A 50-day SMA is recorded $20.03, while a 200-day SMA reached $14.39.
Support And Resistance Levels for Travere Therapeutics Inc (TVTX)
According to the 24-hour chart, there is a support level at 18.97, which, if violated, would cause prices to drop to 18.53. In the upper region, resistance lies at 19.79. The next price resistance is at 20.17. RSI (Relative Strength Index) is 40.93 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.94, which suggests the price will decrease in the coming days. Percent R is at 90.44%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
